This is a test done during pregnancy to check on the baby's heart and the mother's contractions. Doctors use special monitors to watch the baby's heart rate and the strength of the contractions. This helps them see if the baby might be born too early.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Electronic fetal monitoring, also called cardiotocography or CTG, records a baby's heart rate before birth alongside the contractions of the uterus. The printed or on-screen record, called a tracing, shows how the baby's heart rate behaves over time and how it responds when the uterus tightens. The purpose is to spot signs that the baby may not be getting enough oxygen, so the care team can look more closely or decide whether the baby should be delivered sooner. It is used in two main settings. During pregnancy, a short recording called a nonstress test is often offered when there is a higher chance of complications, such as diabetes, high blood pressure, a baby who is not growing as expected, noticeably reduced movements or a pregnancy past 42 weeks. This testing usually starts around 32 to 34 weeks and may be repeated weekly or twice weekly. During labor, continuous monitoring is generally recommended when there are risk factors, such as a previous cesarean birth, high blood pressure needing medicine, diabetes, vaginal bleeding, infection, a breech baby or a baby who is small for their stage of pregnancy. For a labor without known risk factors, the main alternative is intermittent auscultation: a nurse or midwife listens to the baby's heartbeat at set times with a handheld Doppler device or special stethoscope. Professional guidance in the US considers either approach acceptable in low-risk labor, and UK guidance recommends intermittent listening for low-risk labor. Monitoring can switch from one method to the other if circumstances change.
Antenatal monitoring needs little preparation. It is done in a clinic or hospital, and there is usually no special preparation. Some medicines can affect the baby's heart rate pattern, so make sure the team knows what you take. In labor, the team explains why continuous monitoring is being suggested and what the alternatives are. This is a reasonable time to talk about your priorities, such as moving around or using a birth pool, since continuous monitoring can limit both, although some hospitals have wireless monitors that allow more freedom. If internal monitoring might be needed later in labor, it helps if the team already knows about HIV, hepatitis B or C, or active genital herpes. A scalp electrode is generally avoided in these situations because placing it could expose the baby to the infection.
External monitoring is the usual method. Two sensors are held on the abdomen with elastic belts: one uses Doppler ultrasound (sound waves that detect motion) to pick up the baby's heartbeat, and the other senses tightening of the uterus to measure how long contractions last and how far apart they are. It is painless, though the belts can feel snug and may need adjusting as the baby moves. For a nonstress test, you recline or lie down for at least 20 minutes while the heart rate is recorded. Lying flat on your back for long periods is usually avoided, because the weight of the uterus can reduce blood flow; a tilted or side position is common. Internal monitoring is used during labor when the external signal is unreliable or the pattern needs a closer look. A small spiral wire called a fetal scalp electrode is attached through the vagina and cervix to the skin of the baby's head, and a thin tube called an intrauterine pressure catheter may be placed to measure contractions more precisely. Internal monitoring is only possible once the water has broken. Clinicians read the tracing at regular intervals. A steady baseline between 110 and 160 beats per minute, with normal small variations from beat to beat, is a reassuring sign that the baby is coping. Changes in the pattern are common in labor and do not always mean a problem. The team first looks for a cause and may try simple steps, such as changing your position or adjusting medicines that strengthen contractions. If concerns continue or other tests suggest the baby is struggling, they may recommend delivery soon, which is more likely to be by cesarean or with forceps or vacuum.
There is no recovery after external monitoring. The belts come off and you can carry on as usual. A nonstress test is usually read straight away. If the baby's heart rate speeds up at least twice within 20 minutes, the result is called reactive, which is reassuring for now. A nonreactive result means not enough of these speed-ups occurred within 40 minutes. Often the baby was simply asleep, so the test may be extended or the baby gently roused with sound. A nonreactive result can also follow certain medicines, or less often mean the baby is not getting enough oxygen, so further tests such as an ultrasound-based biophysical profile may follow. Because a single test reflects only that moment, people with ongoing risk factors are usually tested again on a schedule. Your care team will explain how to keep track of the baby's movements between tests and when to call them if movements slow down. After internal monitoring, the baby may have a small mark on the scalp where the electrode was attached, which usually heals without treatment. Tell the baby's care team if the spot becomes red, swollen or starts to ooze.
External monitoring itself does not harm the parent or baby. Its main drawback is what it can lead to. Tracings often show patterns that look worrying but turn out to be harmless, and in labor this contributes to more interventions. In a large Cochrane review of trials, continuous monitoring in labor compared with intermittent listening was linked with more cesarean births and more forceps or vacuum deliveries. It roughly halved the rate of newborn seizures, but did not clearly reduce deaths around birth or cerebral palsy. That trade-off is why guidance favors continuous monitoring for higher-risk labors rather than for everyone. The evidence for monitoring during pregnancy is limited. The trials comparing routine antenatal CTG with no CTG were small and older, and they did not show a clear improvement in outcomes for babies. It remains widely used because it is simple and, together with ultrasound and other tests, helps guide the timing of delivery in higher-risk pregnancies. Internal monitoring carries small added risks. A US study of more than 170,000 births found slightly more scalp injuries (about 1.2% compared with 0.9%) and scalp bruising under the skin, called cephalohematoma, when a scalp electrode was used. Infection of the baby's scalp, infection in the uterus and, very rarely, misplacement on the baby's face have been reported.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Electronic Fetal Monitoring, what to expect, or ask the community a question.